Myelopathy in systemic lupus erythematosus: a case report and a review of the literature

被引:0
作者
Hamming, L. [1 ]
van der Meulen, R.
Vergouwen, A.
Siegert, C.
机构
[1] Sint Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands
关键词
Myelopathy; systemic lupus erythematosus; neuropsychiatric lupus erythematosus; ACUTE TRANSVERSE MYELITIS; CENTRAL-NERVOUS-SYSTEM; MANIFESTATIONS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelopathy, a severe condition characterised by paraparesis, sensory deficits and sphincter dysfunction, is one of the neuropsychiatric manifestations that have been described in patients with systemic lupus erythematosus (SLE). SLE-associated myelopathy may confront clinicians with a challenging decision-making process due to the broad differential diagnosis, the lack of disease-specific findings, and the urgency to initiate immunosuppressive therapy early in the course of the disease to favourably affect outcome.
引用
收藏
页码:290 / 292
页数:3
相关论文
共 16 条
[1]   Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE:: a population-based study [J].
Ainiala, H ;
Dastidar, P ;
Loukkola, J ;
Lehtimäki, T ;
Korpela, M ;
Peltola, J ;
Hietaharju, A .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (05) :376-382
[2]  
[Anonymous], 2008, FIR KELL TXB RHEUM
[3]   Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus [J].
Barile-Fabris, L ;
Ariza-Andraca, R ;
Olguín-Ortega, L ;
Jara, LJ ;
Fraga-Mouret, A ;
Miranda-Limón, JM ;
de la Mata, JF ;
Clark, P ;
Vargas, F ;
Alcocer-Varela, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) :620-625
[4]   EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs [J].
Bertsias, G. K. ;
Ioannidis, J. P. A. ;
Aringer, M. ;
Bollen, E. ;
Bombardieri, S. ;
Bruce, I. N. ;
Cervera, R. ;
Dalakas, M. ;
Doria, A. ;
Hanly, J. G. ;
Huizinga, T. W. J. ;
Isenberg, D. ;
Kallenberg, C. ;
Piette, J. C. ;
Schneider, M. ;
Scolding, N. ;
Smolen, J. ;
Stara, A. ;
Tassiulas, I. ;
Tektonidou, M. ;
Tincani, A. ;
van Buchem, M. A. ;
van Vollenhoven, R. ;
Ward, M. ;
Gordon, C. ;
Boumpas, D. T. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) :2074-2082
[5]   OLIGOCLONAL IGG BANDS IN CEREBROSPINAL-FLUID IN VARIOUS NEUROLOGICAL DISEASES [J].
CHU, AB ;
SEVER, JL ;
MADDEN, DL ;
IIVANAINEN, M ;
LEON, M ;
WALLEN, W ;
BROOKS, BR ;
LEE, YJ ;
HOUFF, S .
ANNALS OF NEUROLOGY, 1983, 13 (04) :434-439
[6]   LUPUS TRANSVERSE MYELOPATHY - BETTER OUTCOME WITH EARLY RECOGNITION AND AGGRESSIVE HIGH-DOSE INTRAVENOUS CORTICOSTEROID PULSE TREATMENT [J].
HARISDANGKUL, V ;
DOORENBOS, D ;
SUBRAMONY, SH .
JOURNAL OF NEUROLOGY, 1995, 242 (05) :326-331
[7]   Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus [J].
Heinlein, A. C. ;
Gertner, E. .
LUPUS, 2007, 16 (10) :823-826
[8]   Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation [J].
Katsiari, C. G. ;
Giavri, I. ;
Mitsikostas, D. D. ;
Yiannopoulou, K. G. ;
Sfikakis, P. P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) :556-563
[9]   Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study [J].
Katsumata, Yasuhiro ;
Harigai, Masayoshi ;
Kawaguchi, Yasushi ;
Fukasawa, Chikako ;
Soejima, Makoto ;
Kanno, Tokiko ;
Nishimura, Katsuji ;
Yamada, Takayuki ;
Yamanaka, Hisashi ;
Hara, Masako .
BMC MUSCULOSKELETAL DISORDERS, 2010, 11
[10]   Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature [J].
Kovacs, B ;
Lafferty, TL ;
Brent, LH ;
DeHoratius, RJ .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (02) :120-124